The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...

French lawmakers have voted unanimously to ensure breast cancer patients no longer have to pay out of pocket for the ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to rethink current screening ...

Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.DN-d7ZPu.js ...

A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...

Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.

Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in ...

A far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer produced outcomes ...